UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P₁) modulation

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (2), p.751-756

2011

Volltextzugriff (PDF)

Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation

Glia, 2013-12, Vol.61 (12), p.2009-2022

2013

Volltextzugriff (PDF)

Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation

The Journal of biological chemistry, 2008-03, Vol.283 (12), p.7470-7479

2008

Volltextzugriff (PDF)

Emerging medicinal roles for lysophospholipid signaling

Trends in molecular medicine, 2006-02, Vol.12 (2), p.65-75

2006

Volltextzugriff (PDF)

Lysophosphatidic acid (LPA) and its receptor, LPA 1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation: LPA 1 Regulates Schwann Cell Physiology

Glia, 2013-12, Vol.61 (12), p.2009-2022

2013

Volltextzugriff (PDF)

Lysophosphatidic acid (LPA) and its receptor, LPA sub(1), influence embryonic schwann cell migration, myelination, and cell-to-axon segregation

Glia, 2013-12, Vol.61 (12), p.2009-2022

2013

Volltextzugriff (PDF)

Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation

The Journal of biological chemistry, 2009-12, Vol.284 (52), p.36720-36720

2009

Volltextzugriff (PDF)

Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal DifferentiationS

The Journal of biological chemistry, 2008-03, Vol.283 (12), p.7470-7479

2008

Volltextzugriff (PDF)

GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5

The Journal of biological chemistry, 2006-08, Vol.281 (33), p.23589-23597

2006

Volltextzugriff (PDF)

Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

The Journal of neuroscience, 2000-09, Vol.20 (18), p.7074-7079

2000

Volltextzugriff (PDF)

Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

The Journal of neuroscience, 2002-08, Vol.22 (15), p.6747-6755

2002

Volltextzugriff (PDF)

Time-Dependent Descending Facilitation from the Rostral Ventromedial Medulla Maintains, But Does Not Initiate, Neuropathic Pain

The Journal of neuroscience, 2002-06, Vol.22 (12), p.5129-5136

2002

Volltextzugriff (PDF)

Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor

The Journal of neuroscience, 2001-07, Vol.21 (14), p.5281-5288

2001

Volltextzugriff (PDF)

GPR92 as a New G12/13- and G sub(q)-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA sub(5)

The Journal of biological chemistry, 2006-08, Vol.281 (33), p.23589-23597

2006

Volltextzugriff (PDF)

GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA

The Journal of biological chemistry, 2006, Vol.281 (33), p.23589-23597

2006

Volltextzugriff (PDF)

Amlodipine, a Calcium Channel Inhibitor, and Cocaine and Ethanol's Reinforcing Effects

Pharmacology, biochemistry and behavior, 1999-11, Vol.64 (3), p.567-572

1999

Volltextzugriff (PDF)

Inhibition of Neuropathic Pain by Selective Ablation of Brainstem Medullary Cells Expressing the {micro}-Opioid Receptor

The Journal of neuroscience, 2001-07, Vol.21 (14), p.5281

2001

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P₁) modulation

Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell-to-axon segregation

Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation

Emerging medicinal roles for lysophospholipid signaling

Lysophosphatidic acid (LPA) and its receptor, LPA 1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation: LPA 1 Regulates Schwann Cell Physiology

Lysophosphatidic acid (LPA) and its receptor, LPA sub(1), influence embryonic schwann cell migration, myelination, and cell-to-axon segregation

Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation

Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal DifferentiationS

GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5

Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance

Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers

Time-Dependent Descending Facilitation from the Rostral Ventromedial Medulla Maintains, But Does Not Initiate, Neuropathic Pain

Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor

GPR92 as a New G12/13- and G sub(q)-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA sub(5)

GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA

Amlodipine, a Calcium Channel Inhibitor, and Cocaine and Ethanol's Reinforcing Effects

Inhibition of Neuropathic Pain by Selective Ablation of Brainstem Medullary Cells Expressing the {micro}-Opioid Receptor

Suchergebnisse filtern